CompaniesByCap
URGN
Urogen Pharma Ltd. (URGN)
NASDAQ · Healthcare

Urogen Pharma Ltd. Cash Flow 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Operating Activities
Operating Cash Flow-162.4M-96.8M-76.4M-87.6M-84.9M-105.9M-71.0M-37.3M-9.6M4.2M
Depreciation & Amort.
Investing Activities
Capital Expenditure289,000295,000194,000254,000752,0001.2M325,000560,000271,000695,000
Free Cash Flow-162.7M-97.1M-76.6M-87.8M-85.6M-107.1M-71.3M-37.9M-9.8M3.5M
Financing Activities
Dividends Paid
Stock Buybacks

Urogen Pharma Ltd. Cash Flow — FAQ

Urogen Pharma Ltd. (URGN) cash flow over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see URGN's cash flow history?

The chart and table above show Urogen Pharma Ltd.'s cash flow by year and by quarter, including the growth rate.